Keith Loebner
Director at Integrated Biosciences.
Raised on Integrated Biosciences filings
$68.4M
of $100M offered across 1 Form D filing
- Form D filings
- 1
- Teammates
- 2
- Last filing
- Aug 5, 2026
Company
Integrated Biosciences
Biotech · Redwood City, CA
Small-molecule drugs for aging and cardiometabolic disease
Small-molecule drugs for aging and cardiometabolic disease
- Investors
- 39
- Founded
- 2022
- Still open
- $31.6M
Integrated Biosciences filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Aug 5, 2026 | Equity | $68.4M/ $100M | Form D |
- EquityFiled Aug 5, 2026Form D$68.4M/ $100M
